Myriad Genetics shares fall 6.2% after Piper Sandler downgrade
Myriad Genetics shares fell 6.2% in the afternoon session after Piper Sandler double-downgraded the stock to Underweight, saying major strategic action is likely needed.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.